FDA.reportPublic FDA data

treprostinil 0.08 MG Inhalation Powder [Tyvaso]

RxCUI
2697739
RxNorm name
treprostinil 0.08 MG Inhalation Powder [Tyvaso]
Display name
treprostinil 0.08 MG Inhalation Powder [Tyvaso]
Full name
treprostinil 0.08 MG Inhalation Powder [Tyvaso]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ddc3d400-bcb3-4b09-aae2-0768b10a5b0ftreprostinil 0.08 MG Inhalation Powder [Tyvaso]SBD14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0fTyvaso 80 MCG Inhalation PowderSY14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0fTYVASO DPI 80 MCG Inhalation PowderPSN14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0fTyvaso 0.08 MG Inhalation PowderSY14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120